Switzerland vs Togo: Treatment success rate for patients treated for MDR-TB
Switzerland
60.0%
in 2022
Togo
60.0%
in 2022
Switzerland rank
120th
Togo rank
120th
Treatment success rate for patients treated for MDR-TB over time
- Switzerland
- Togo
How they compare
Switzerland currently reports 60.0% against 60.0% in Togo, a difference of 0.0%.
The two have swapped places 2 times across 8 shared years of data; in 2014 it was Togo ahead.
Switzerland ranks 120th and Togo ranks 120th of 163 countries.
Togo has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Switzerland | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 72.8% | 80.0% | 7.2% | Togo |
| 2020s | 53.3% | 61.7% | 8.3% | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Switzerland or Togo?
- Switzerland, at 60.0% against 60.0% in Togo as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Switzerland and Togo?
- 0.0%, with Switzerland ahead.
- How many years of comparable data are there for Switzerland and Togo?
- 8 years are reported by both, from 2014 to 2022.
- How do Switzerland and Togo rank globally for treatment success rate for patients treated for mdr-tb?
- Switzerland ranks 120th and Togo ranks 120th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.